Trial Profile
An Observational Comparison Of Natalizumab & Fingolimod Using JCV Serology To Randomize Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 19 Sep 2014 New trial record